CN105687935A - 一种治疗足踝扭伤的消肿止痛药膏及其制备方法 - Google Patents
一种治疗足踝扭伤的消肿止痛药膏及其制备方法 Download PDFInfo
- Publication number
- CN105687935A CN105687935A CN201610103509.8A CN201610103509A CN105687935A CN 105687935 A CN105687935 A CN 105687935A CN 201610103509 A CN201610103509 A CN 201610103509A CN 105687935 A CN105687935 A CN 105687935A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- consumption
- reducing swelling
- alleviating pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000002193 Pain Diseases 0.000 title claims abstract description 69
- 230000008961 swelling Effects 0.000 title claims abstract description 55
- 239000002674 ointment Substances 0.000 title claims abstract description 53
- 206010024453 Ligament sprain Diseases 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims description 23
- 239000000052 vinegar Substances 0.000 claims abstract description 20
- 235000021419 vinegar Nutrition 0.000 claims abstract description 20
- 239000003814 drug Substances 0.000 claims description 48
- 241000229143 Hippophae Species 0.000 claims description 23
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 22
- 240000005175 Turpinia pomifera Species 0.000 claims description 21
- 241000722721 Capparis Species 0.000 claims description 20
- 241000628997 Flos Species 0.000 claims description 20
- 235000003935 Hippophae Nutrition 0.000 claims description 19
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 19
- 241000180649 Panax notoginseng Species 0.000 claims description 19
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 19
- 239000004332 silver Substances 0.000 claims description 19
- 229910052709 silver Inorganic materials 0.000 claims description 19
- 238000009835 boiling Methods 0.000 claims description 18
- 239000003871 white petrolatum Substances 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000003763 carbonization Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 26
- 235000003145 Hippophae rhamnoides Nutrition 0.000 abstract description 4
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Inorganic materials O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 abstract description 3
- 235000015655 Crocus sativus Nutrition 0.000 abstract description 2
- 244000124209 Crocus sativus Species 0.000 abstract description 2
- 240000008027 Akebia quinata Species 0.000 abstract 1
- 235000007756 Akebia quinata Nutrition 0.000 abstract 1
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 241001406863 Capparis acutifolia Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000017008 Dioscorea nipponica Nutrition 0.000 abstract 1
- 241000908494 Dioscorea nipponica Species 0.000 abstract 1
- 241001362411 Epimedium sagittatum Species 0.000 abstract 1
- 241001573322 Euonymus nitidus Species 0.000 abstract 1
- 244000308638 Geum urbanum Species 0.000 abstract 1
- 235000016578 Geum urbanum Nutrition 0.000 abstract 1
- 241000931143 Gleditsia sinensis Species 0.000 abstract 1
- 240000000950 Hippophae rhamnoides Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 241001653642 Russula nigricans Species 0.000 abstract 1
- 241000915604 Scutellaria barbata Species 0.000 abstract 1
- 240000009022 Smilax rotundifolia Species 0.000 abstract 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 abstract 1
- 241000316351 Taxillus sutchuenensis Species 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 241001436151 Turpinia arguta Species 0.000 abstract 1
- 244000309464 bull Species 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 23
- 210000004369 blood Anatomy 0.000 description 23
- 210000003041 ligament Anatomy 0.000 description 20
- 210000000544 articulatio talocruralis Anatomy 0.000 description 17
- 210000003205 muscle Anatomy 0.000 description 15
- 230000017531 blood circulation Effects 0.000 description 12
- 210000000988 bone and bone Anatomy 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 11
- 210000003423 ankle Anatomy 0.000 description 10
- 208000014674 injury Diseases 0.000 description 10
- 210000002683 foot Anatomy 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 208000006820 Arthralgia Diseases 0.000 description 8
- 208000010040 Sprains and Strains Diseases 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 230000008736 traumatic injury Effects 0.000 description 8
- 201000000736 Amenorrhea Diseases 0.000 description 7
- 206010001928 Amenorrhoea Diseases 0.000 description 7
- 231100000540 amenorrhea Toxicity 0.000 description 7
- 210000004233 talus Anatomy 0.000 description 7
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 5
- 230000002040 relaxant effect Effects 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 210000002435 tendon Anatomy 0.000 description 5
- 210000002303 tibia Anatomy 0.000 description 5
- 241001061264 Astragalus Species 0.000 description 4
- 241000469816 Varus Species 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 235000006533 astragalus Nutrition 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 4
- 206010025482 malaise Diseases 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- 206010061223 Ligament injury Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000002082 fibula Anatomy 0.000 description 3
- 208000017561 flaccidity Diseases 0.000 description 3
- -1 flavone compound Chemical class 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 210000001624 hip Anatomy 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 150000002596 lactones Chemical class 0.000 description 3
- 210000001699 lower leg Anatomy 0.000 description 3
- ZMNSRFNUONFLSP-UHFFFAOYSA-N mephenoxalone Chemical compound COC1=CC=CC=C1OCC1OC(=O)NC1 ZMNSRFNUONFLSP-UHFFFAOYSA-N 0.000 description 3
- 229960001030 mephenoxalone Drugs 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- 229960001285 quercetin Drugs 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 201000003068 rheumatic fever Diseases 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 150000003648 triterpenes Chemical class 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 208000025978 Athletic injury Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- HJXMNVQARNZTEE-UHFFFAOYSA-N Butylphthalide Chemical compound C1=CC=C2C(CCCC)OC(=O)C2=C1 HJXMNVQARNZTEE-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 2
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- OPMNROCQHKJDAQ-FKSUSPILSA-N loline Chemical compound C1C[C@@H]2O[C@H]3[C@H](NC)[C@@H]2N1C3 OPMNROCQHKJDAQ-FKSUSPILSA-N 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- IGGUPRCHHJZPBS-UHFFFAOYSA-N nonacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCC IGGUPRCHHJZPBS-UHFFFAOYSA-N 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- KFUCYPGCMLPUMT-UHFFFAOYSA-N perlolyrine Chemical compound O1C(CO)=CC=C1C1=NC=CC2=C1NC1=CC=CC=C21 KFUCYPGCMLPUMT-UHFFFAOYSA-N 0.000 description 2
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 2
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 241000068277 Apios fortunei Species 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 241001503987 Clematis vitalba Species 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 1
- 241000596148 Crocus Species 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241001653121 Glenoides Species 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- 206010060820 Joint injury Diseases 0.000 description 1
- 241000220645 Leonotis nepetifolia Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010024452 Ligament laxity Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 241001247900 Marsdenia Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 240000005218 Phyla nodiflora Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000221987 Russula Species 0.000 description 1
- 241000221986 Russulaceae Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- TUCIXUDAQRPDCG-UHFFFAOYSA-N benzene-1,2-diol Chemical compound OC1=CC=CC=C1O.OC1=CC=CC=C1O TUCIXUDAQRPDCG-UHFFFAOYSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 210000003995 blood forming stem cell Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 208000009973 brain hypoxia - ischemia Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229950005197 butylphthalide Drugs 0.000 description 1
- 210000000459 calcaneus Anatomy 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- OVSVTCFNLSGAMM-KGBODLQUSA-N cis-phytofluene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/C=C/C=C(C)/CCC=C(/C)CCC=C(C)C)C)C)C)C OVSVTCFNLSGAMM-KGBODLQUSA-N 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 210000004439 collateral ligament Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- OPMNROCQHKJDAQ-UHFFFAOYSA-N festucine Natural products C1CC2OC3C(NC)C2N1C3 OPMNROCQHKJDAQ-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 210000000281 joint capsule Anatomy 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- 210000003052 knee medial collateral ligament Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- OVSVTCFNLSGAMM-UZFNGAIXSA-N phytofluene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=C\C=C(/C)\C=C\C=C(C)CCC=C(C)CCC=C(C)C OVSVTCFNLSGAMM-UZFNGAIXSA-N 0.000 description 1
- 235000002677 phytofluene Nutrition 0.000 description 1
- ZYSFBWMZMDHGOJ-SGKBLAECSA-N phytofluene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)C=CC=C(/C)CCC=C(C)C)C)C)C)C ZYSFBWMZMDHGOJ-SGKBLAECSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 235000020245 plant milk Nutrition 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 1
- 229910052683 pyrite Inorganic materials 0.000 description 1
- 239000011028 pyrite Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titanium dioxide Inorganic materials O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- ZIUDAKDLOLDEGU-UHFFFAOYSA-N trans-Phytofluen Natural products CC(C)=CCCC(C)CCCC(C)CC=CC(C)=CC=CC=C(C)C=CCC(C)CCCC(C)CCC=C(C)C ZIUDAKDLOLDEGU-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种治疗足踝扭伤的消肿止痛药膏,取下述重量配比的主要原料制备而成:桑寄生10-20份,皂角刺3-9份,红花3-10份,独行千里6-12份,木通3-9份,川芎3-10份,三七5-10份,淫羊藿10-30份,半枝莲3-6份,土茯苓2-6份,刺五加10-30份,龟甲6-12份,三百银9-15份,无名异(醋炙)6-12份,山香圆8-16份,番红花3-9份,川牛膝3-10份,穿山龙8-16份,黑红菇10-30份,沙棘1-5份。该消肿止痛药膏对足踝扭伤效果显著,不仅有止痛消肿的功效,还能够根治足踝扭伤之症,本发明多选用地方常见药材,价格低廉,减轻了患者的经济负担。
Description
技术领域
本发明公开了一种消肿止痛药膏,尤其是治疗足踝扭伤的消肿止痛药膏及其制备方法。属中医中药领域。
背景技术
足踝:小腿于脚之间部位的左右两侧的突起,是由胫骨和腓骨下端的膨大部分形成的。踝关节(ankle joint),由胫、腓骨下端的关节面与距骨滑车构成,故又名距骨小腿关节。胫骨的下关节面及内、外踝关节面共同形成的“冂”形的关节窝,容纳距骨滑车(关节头),由于滑车关节面前宽后窄,当足背屈时,较宽的前部进入窝内,关节稳定;但在跖屈时,如走下坡路时滑车较窄的后部进入窝内,踝关节松动且能作侧方运动,此时踝关节容易发生扭伤,其中以内翻损伤最多见,因为外踝比内踝长而低,可阻止距骨过度外翻。
特点:关节囊前后较薄,两侧较厚,并有韧带加强。胫侧副韧带为一强韧的三角形韧带,又名三角韧带,位于关节的内侧。起自内踝,呈扇形向下止于距、跟、舟三骨。由于附着部不同,由后向前可分为四部:距胫后韧带、跟胫韧带、胫舟韧带和位于其内侧的距胫前韧带。三角韧带主要限制足的背屈,前部纤维则限制足的跖屈。腓侧副韧带位于关节的外侧,由从前往后排列有距腓前、跟腓、距腓后三条独立的韧带组成,连结于外踝与距、跟骨之间。距腓后韧带可防止小腿骨向前脱位。当足过度跖屈内翻时,易损伤距腓前韧带及跟腓韧带。踝关节属滑车关节,可沿通过横贯距骨体的冠状轴做背屈及跖屈运动。足尖向上,足与小腿间的角度小于90°叫背屈,反之,足尖向下,足与小腿间的角度大于直角叫做跖屈。在跖屈时,足可做一定范围的侧方运动。踝关节扭伤是临床常见的疾病,在关节及韧带损伤中是发病率最高的疾病。踝关节是人体距离地面最近的负重关节,也就是说踝关节是全身负重最多的关节。踝关节的稳定性对于日常的活动和体育运动的正常进行起重要的作用。踝关节周围的韧带损伤都属于踝关节扭伤的范畴。踝关节扭伤可能导致的损伤包括外踝的距腓前韧带跟腓韧带,内踝三角韧带,下胫腓横韧带等。
踝关节扭伤是最高发的运动损伤,约占所有运动损伤的40%。踝关节由胫骨腓骨远端和距骨构成。由内外踝和胫骨后缘构成踝穴,距骨上面的鞍型关节面位于踝穴中。距骨的鞍型关节面前宽后窄,背伸时较宽处进入踝穴,跖屈时较窄部进入踝穴,所以踝关节在跖屈位稍松动,其解剖和生理特点决定踝关节在跖屈时比较容易发生内翻外翻扭伤。又因为踝关节外踝腓骨较长踝穴较深而内踝胫骨较短踝穴较浅,故踝关节更易发生内翻扭伤,外踝韧带包括距腓前韧带及跟腓韧带的损伤更常见。踝关节外翻扭伤虽不易发生,一旦出现却很严重。如发生断裂一般都会引起踝关节不稳,且多同时合并其他韧带损伤和骨折。
临床表现:踝关节扭伤的临床表现包括伤后迅即出现扭伤部位的疼痛和肿胀,随后出现皮肤淤斑。严重者患足因为疼痛肿胀而不能活动。外踝扭伤时,患者在尝试行足内翻时疼痛症状加剧。内侧三角韧带损伤时,患者在尝试行足外翻时疼痛症状加剧。经休息后疼痛和肿胀可能消失,会出现因韧带松弛导致的踝关节不稳,反复扭伤。
在已有治疗足踝扭伤的药物中,申请公布号 CN103536861A(申请号201310542218.5)公开了一种治疗足踝扭伤的中药外用洗剂,其特征在于:由以下重量份数的中药材经浸泡、煮沸制成:伸筋草18-35
份、透骨草18-35 份、五加皮10-18
份、桑枝8-15 份、木瓜10-15份、川牛膝10-15 份、路路通5-10 份、王不留行5-10 份、独行千里10-15 份、红花10-15 份、苏木15-20 份、三棱10-18 份、莪术10-18 份,组方复杂,效果单一,不能真正的治疗足踝扭伤。
发明内容
针对现有治疗足踝扭伤疗效不足的现状,本发明的目的之一在于提供一种治疗足踝扭伤的消肿止痛药膏,具有易操作、疗效显著的特点,并且它采用地方上较为常见的中药材作为原料,成本低廉。
本发明的另一目的就是提供上述消肿止痛药膏的制备方法。
本发明的上述目的是通过以下技术方案来实现的:
一种治疗足踝扭伤的消肿止痛药膏,取下述重量配比的主要原料制备而成:桑寄生10-20份,皂角刺3-9份,红花3-10份,独行千里6-12份,木通3-9份,川芎3-10份,三七5-10份,淫羊藿10-30份,半枝莲3-6份,土茯苓2-6份,刺五加10-30份,龟甲6-12份,三百银9-15份,无名异(醋炙)6-12份,山香圆8-16份,番红花3-9份,川牛膝3-10份,穿山龙8-16份,黑红菇10-30份(优选的,黑红菇10.5-29.5份),沙棘1-5份。
一种治疗足踝扭伤的消肿止痛药膏,更加优选的方案,取下述重量配比的主要原料制备而成:桑寄生12-18份,皂角刺4-7份,红花4-8份,独行千里7-10份,木通4-6份,川芎5-8份,三七6-8份,淫羊藿12-20份,半枝莲4-5份,土茯苓3-5份,刺五加12-28份,龟甲8-10份,三百银10-12份,无名异(醋炙)8-12份,山香圆10-15份,番红花4-8份,川牛膝4-9份,穿山龙10-14份,黑红菇15-25份,沙棘2-4份。
一种治疗足踝扭伤的消肿止痛药膏,最佳的方案,取下述重量配比的主要原料制备而成:桑寄生15份,皂角刺6份,红花6份,独行千里8份,木通5份,川芎6份,三七7份,淫羊藿15份,半枝莲4.5份,土茯苓4份,刺五加15份,龟甲9份,三百银11份,无名异(醋炙)10份,山香圆12份,番红花5份,川牛膝5份,穿山龙12份,黑红菇20份,沙棘3份。
上述消肿止痛药膏的制备步骤如下:
①取番红花和川牛膝置于小火上,烧至外部焦黑,使药物表面部分炭化,然后研磨备用;
②将皂角刺置于预热好的容器内,用中火炒至表面深黄色,内部浅黄色时取出晾凉至室温,碾碎,用90-100目筛筛净,制成炒皂角刺;
③将桑寄生、红花、独行千里、木通、川芎、三七、淫羊藿、半枝莲、土茯苓、刺五加、龟甲、三百银、无名异(醋炙)、山香圆、穿山龙、黑红菇和沙棘用黄酒喷匀,黄酒的用量是原料药用量的0.4-0.8倍,置于锅内微炒5-15分钟,晾至酥脆,研磨成细末过80-120目筛待用;
④将步骤①-③所得物混匀,加水煎煮2次,每次用水量是混合药物的2-4倍,每次都是先武火煎开,转文火煎煮40-80分钟,合并煎液;
⑤将步骤④所得煎液中加入白凡士林,白凡士林的用量为煎液重量的0.2-0.4倍,一边煎煮一边搅拌5-15分钟,放凉即得药膏。
上述消肿止痛药膏的制备方法,步骤②用93-98目筛筛净,制成炒皂角刺(优选用95目筛筛净,制成炒皂角刺)。
上述消肿止痛药膏的制备方法,步骤③黄酒的用量是原料药用量的0.5-0.7倍(优选黄酒的用量是原料药用量的0.6倍)。
上述消肿止痛药膏的制备方法,步骤③置于锅内微炒8-13分钟(优选置于锅内微炒10分钟)。
上述消肿止痛药膏的制备方法,步骤④每次用水量是混合药物的2.5-3.5倍(优选每次用水量是混合药物的3倍)。
上述消肿止痛药膏的制备方法,步骤④先武火煎开,转文火煎煮50-70分钟(优选的先武火煎开,转文火煎煮60分钟)。
上述消肿止痛药膏的制备方法,步骤⑤白凡士林的用量为煎液重量的0.25-0.35倍,一边煎煮一边搅拌8-13分钟(优选的白凡士林的用量为煎液重量的0.3倍,一边煎煮一边搅拌10分钟)。
使用方法:为使本发明消肿止痛药膏达到最佳治疗效果,每日两次,于早晚饭后半小时,取3g,涂抹在患处。
该消肿止痛药膏对足踝扭伤效果显著,不仅有止痛消肿的功效,还能够根治足踝扭伤之症,本发明多选用地方常见药材,价格低廉,减轻了患者的经济负担。
各原料药的药理功效分别为:
桑寄生:桑寄生叶中含黄酮类化合物:槲皮素(quercetin),槲皮甙(quercitrin)及少量的右旋儿茶酚(catechol)性味:苦甘,平。归经:入肝、肾经。功能主治:补肝肾,强筋骨,除风湿,通经络,益血,安胎。治腰膝酸痛,筋骨痿弱,偏枯,脚气,风寒湿痹,胎漏血崩,产后乳汁不下,治久咳,舌纵、 眩晕。
皂角刺:味辛,性温。归经:归肝、胃经。功效:消肿托毒,排脓,杀虫。主治:用于痈疽初起或脓成不溃;外治疥癣麻风。
红花:主产河南、湖南、四川、新疆、西藏等地。活血通经,散瘀止痛,有助于治经闭、痛经、恶露不行、胸痹心痛、瘀滞腹痛、胸胁刺痛、跌打损伤、疮疡肿痛疗效。有活血化瘀,散湿去肿的功效,避免孕妇使用,否则会造成流产。
独行千里:性味归经苦、涩,平。有毒。功能主治:活血散瘀,解痉止痛。根:用于风湿关节痛,筋骨不舒,咽喉肿痛,牙痛,腹痛(特别是痉挛性疼痛),闭经;外用治疮疖肿毒,跌打损伤。叶:外用治跌打损伤。
木通:味苦,性寒。归经:归心、小肠、膀胱经。功能:有利尿通淋,清心除烦,通经下乳的功效。主治:用于淋证,水肿,心烦尿赤,口舌生疮,经闭乳少,湿热痹痛。
川芎:为伞形科藳木属植物川芎的根茎。成分:根茎含多种内酯:川芎嗪,黑麦草碱或川芎哚,藳木内酯,川芎萘呋内酯,丁基苯酞,双苯酞类,蛇床内酯等。药性:辛,温。归肝、胆心包经。功用主治:活血祛瘀,行气开郁,祛风止痛。主治月经不调,经闭痛经,产后瘀滞腹痛,症瘕肿块,胸胁疼痛,头痛眩晕,风寒湿痹,跌打损伤,痈疽疮疡。
三七:甘、微苦,温。归经:归肝、胃经。功效:散瘀止血,消肿定痛。主治:用于咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹刺痛,跌扑肿痛。
淫羊藿:淫羊藿具有延缓衰老、降血压,降血糖,降血脂。改善脑缺血缺氧、降低血液黏度、抑制体外血栓形成、刺激骨髓DNA的合成、增加外周血白细胞及骨髓造血干细胞的数量、提高免疫力、促进骨骼生长、预防骨质疏松、抗炎,抗病毒,抗肿瘤、对抗抗癌药物的副作用。
半枝莲:半支莲全草入药,具有清热解毒、活血祛瘀、消肿止痛、抗癌等功能。性寒味酸,全草含多种维生素、微量元素及氨基酸等成分。有凉血解毒,散瘀止痛,消肿和清热利湿之功效。
土茯苓:味甘、淡,性平。有解毒,除湿,通利关节之功效,主要用于梅毒及汞中毒所致的肢体拘挛,筋骨疼痛;湿热淋浊,带下,痈肿,瘰疬,疥癣。
刺五加:属于补气药,具有补虚扶弱的功效,可来预防或治疗体质虚弱之症候,滋补强壮,延年益寿,用于风湿痹痛,腰膝酸痛。本品功能祛风湿,又能补肝肾,强筋骨,可用于风湿痹痛、筋骨拘挛、腰膝酸痛等症。
龟甲:具有滋阴潜阳,益肾强骨,养血补心,固经止崩之功效。常用于阴虚潮热,骨蒸盗汗,头晕目眩,虚风内动,筋骨痿软,心虚健忘,崩漏经多。
三百银:又名白杜仲、婆婆针线包,为萝藦科牛奶菜属植物牛奶菜的全株或根。药性:粗壮木质藤本,本品呈长短大小不规则的段块状,味微苦,性平。成分:全草含三萜和脂肪烃类,三萜类有羽扇豆醇乙酸酯等,脂肪烃类有三十一烷、二十九烷等。根据现代药理研究发现,该药具有祛风湿,强筋骨,解蛇毒的功效,用于风湿性关节炎,跌打扭伤,腰肌损伤。
无名异(醋炙):又名土子、干子、秃子、铁砂,为氧化物类金红石族矿物软锰矿。药性:本品为结核状、块状集合体,棕黑色或黑色,体较轻,质脆,微有土腥气,味甘,性平。成分:主要成分为软锰矿,应有水锰矿、硬锰矿及锰土和粘土矿物。根据现代药理研究发现,该药具有祛瘀止血、消肿止痛、生肌敛疮的功效,用于跌打损伤,金疮出血,痈肿疮疡,水火烫伤。
山香圆:又名两剑指、七寸钉,为省沽油科山香圆属植物锐尖山香圆的根或叶。药性:味苦,性寒。成分:其叶含熊果酸,黄酮化合物芦丁,还含有肉豆蔻酸,胡萝卜苷等。根据现代药理研究发现,该药具有抑菌、抗炎、活血散瘀、消肿止痛的功效,用于跌打损伤,脾脏肿大,咽喉炎等。
番红花:为鸢尾番红花属植物番红花的柱头。成分:柱头含挥发油成分30多个。还含色素类:藏红花苷,藏红花酸,杧果苷-6’-O-藏红花酰基1’’-O-β-D-葡萄糖苷脂;甾醇类:菜油甾醇,豆甾醇等。三萜类:熊果酸,齐墩果酸;脂肪酸类:棕榈酸,棕榈油酸,油酸,亚油酸,亚麻酸;类胡萝卜素类:八氢番茄烃,六氢番茄烃,等。药性:甘,平。归心、肝经。功用主治:活血祛瘀,散瘀开解。主治痛经,经闭,月经不调,产后恶露不净,腹中包块疼痛,跌扑损伤,忧郁痞闷,惊悸,温病发斑,麻疹。
川牛膝:味甘、微苦,性平。归经:归肝、肾经。功效:逐瘀通经,通利关节,利尿通淋。主治:用于经闭症瘕,胞衣不下,跌扑损伤,风湿痹痛,足痿筋挛,尿血血淋等证。
穿山龙:性温,味甘、苦。功能主治:舒筋活血,止痛消肿、舒筋活血,祛风止痛。用于腰腿疼痛、风湿痛、风湿关节痛、筋骨麻木、大骨节病、跌打损伤、闪腰、咳嗽喘息、气管炎、支气管炎。
黑红菇:为红菇科红菇属真菌黑红菇的子实体。成分:子实体含麦角甾醇,5,7-麦角甾二烯-3β-醇。药性:《全国中草药汇编》:“微咸,温。”功用主治:祛风散寒除湿,舒筋活络。主治风寒湿痹,腰腿疼痛,关节痛,手足麻木,四肢抽搐。
沙棘:为胡颓子科沙棘属植物中国沙棘和云南沙棘的果实。成分:沙棘果实含黄铜类成分:异鼠李素,异鼠李素-3-O-ß-D-葡萄糖苷,芸香苷,紫云英苷以及槲皮素和山奈酚为苷元的低糖苷等。药性:《西藏常用中草药》:“性温,味酸、涩。”功用主治:止痛消肿、舒筋活血,健胃消食,活血散瘀。主治咳嗽痰多,肺脓肿,消化不良,食积腹痛,胃痛,肠炎,闭经,跌打瘀肿。
本发明消肿止痛药膏基于中医中药治疗足踝扭伤的原理。选用的药材均有止痛消肿、舒筋活血的功效,针对足踝扭伤辨证施治,属于标本兼治的组方。对足踝扭伤有极好的治疗作用。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不被此限制。
实施例 1:一种治疗足踝扭伤的消肿止痛药膏,取下述重量配比的主要原料制备而成(每份取10g):桑寄生10份,皂角刺3份,红花3份,独行千里6份,木通3份,川芎3份,三七5份,淫羊藿10份,半枝莲3份,土茯苓2份,刺五加10份,龟甲6份,三百银9份,无名异(醋炙)6份,山香圆8份,番红花3份,川牛膝3份,穿山龙8份,黑红菇10份,沙棘1份。
一种治疗足踝扭伤的消肿止痛药膏的制备方法,步骤如下:
①取番红花和川牛膝置于小火上,烧至外部焦黑,使药物表面部分炭化,然后研磨备用;
②将皂角刺置于预热好的容器内,用中火炒至表面深黄色,内部浅黄色时取出晾凉至室温,碾碎,用90目筛筛净,制成炒皂角刺;
③将桑寄生、红花、独行千里、木通、川芎、三七、淫羊藿、半枝莲、土茯苓、刺五加、龟甲、三百银、无名异(醋炙)、山香圆、穿山龙、黑红菇和沙棘用黄酒喷匀,黄酒的用量是原料药用量的0.4倍,置于锅内微炒5分钟,晾至酥脆,研磨成细末过80目筛待用;
④将步骤①-③所得物混匀,加水煎煮2次,每次用水量是混合药物的2倍,每次都是先武火煎开,转文火煎煮40-80分钟,合并煎液;
⑤将步骤④所得煎液中加入白凡士林,白凡士林的用量为煎液重量的0.2倍,一边煎煮一边搅拌5分钟,放凉即得药膏。
实施例 2:一种治疗足踝扭伤的消肿止痛药膏,取下述重量配比的主要原料制备而成(每份取10g):桑寄生20份,皂角刺9份,红花10份,独行千里12份,木通9份,川芎10份,三七10份,淫羊藿30份,半枝莲6份,土茯苓6份,刺五加30份,龟甲12份,三百银15份,无名异(醋炙)12份,山香圆16份,番红花9份,川牛膝10份,穿山龙16份,黑红菇30份,沙棘5份。
一种治疗足踝扭伤的消肿止痛药膏的制备方法,步骤如下:
①取番红花和川牛膝置于小火上,烧至外部焦黑,使药物表面部分炭化,然后研磨备用;
②将皂角刺置于预热好的容器内,用中火炒至表面深黄色,内部浅黄色时取出晾凉至室温,碾碎,用100目筛筛净,制成炒皂角刺;
③将桑寄生、红花、独行千里、木通、川芎、三七、淫羊藿、半枝莲、土茯苓、刺五加、龟甲、三百银、无名异(醋炙)、山香圆、穿山龙、黑红菇和沙棘用黄酒喷匀,黄酒的用量是原料药用量的0.8倍,置于锅内微炒15分钟,晾至酥脆,研磨成细末过120目筛待用;
④将步骤①-③所得物混匀,加水煎煮2次,每次用水量是混合药物的4倍,每次都是先武火煎开,转文火煎煮80分钟,合并煎液;
⑤将步骤④所得煎液中加入白凡士林,白凡士林的用量为煎液重量的0.4倍,一边煎煮一边搅拌15分钟,放凉即得药膏。
实施例 3:一种治疗足踝扭伤的消肿止痛药膏,取下述重量配比的主要原料制备而成(每份取10g):桑寄生12份,皂角刺4份,红花4份,独行千里7份,木通4份,川芎5份,三七6份,淫羊藿12份,半枝莲4份,土茯苓3份,刺五加12份,龟甲8份,三百银10份,无名异(醋炙)8份,山香圆10份,番红花4份,川牛膝4份,穿山龙10份,黑红菇15份,沙棘2份。
一种治疗足踝扭伤的消肿止痛药膏的制备方法,步骤如下:
①取番红花和川牛膝置于小火上,烧至外部焦黑,使药物表面部分炭化,然后研磨备用;
②将皂角刺置于预热好的容器内,用中火炒至表面深黄色,内部浅黄色时取出晾凉至室温,碾碎,用93目筛筛净,制成炒皂角刺;
③将桑寄生、红花、独行千里、木通、川芎、三七、淫羊藿、半枝莲、土茯苓、刺五加、龟甲、三百银、无名异(醋炙)、山香圆、穿山龙、黑红菇和沙棘用黄酒喷匀,黄酒的用量是原料药用量的0.5倍,置于锅内微炒8分钟,晾至酥脆,研磨成细末过90目筛待用;
④将步骤①-③所得物混匀,加水煎煮2次,每次用水量是混合药物的2.5倍,每次都是先武火煎开,转文火煎煮50分钟,合并煎液;
⑤将步骤④所得煎液中加入白凡士林,白凡士林的用量为煎液重量的0.25倍,一边煎煮一边搅拌8分钟,放凉即得药膏。
实施例 4 :一种治疗足踝扭伤的消肿止痛药膏,取下述重量配比的主要原料制备而成(每份取10g):桑寄生18份,皂角刺7份,红花8份,独行千里10份,木通6份,川芎8份,三七8份,淫羊藿20份,半枝莲5份,土茯苓5份,刺五加28份,龟甲10份,三百银12份,无名异(醋炙)12份,山香圆15份,番红花8份,川牛膝9份,穿山龙14份,黑红菇25份,沙棘4份。
一种治疗足踝扭伤的消肿止痛药膏的制备方法,步骤如下:
①取番红花和川牛膝置于小火上,烧至外部焦黑,使药物表面部分炭化,然后研磨备用;
②将皂角刺置于预热好的容器内,用中火炒至表面深黄色,内部浅黄色时取出晾凉至室温,碾碎,用98目筛筛净,制成炒皂角刺;
③将桑寄生、红花、独行千里、木通、川芎、三七、淫羊藿、半枝莲、土茯苓、刺五加、龟甲、三百银、无名异(醋炙)、山香圆、穿山龙、黑红菇和沙棘用黄酒喷匀,黄酒的用量是原料药用量的0.7倍,置于锅内微炒13分钟,晾至酥脆,研磨成细末过110目筛待用;
④将步骤①-③所得物混匀,加水煎煮2次,每次用水量是混合药物的3.5倍,每次都是先武火煎开,转文火煎煮70分钟,合并煎液;
⑤将步骤④所得煎液中加入白凡士林,白凡士林的用量为煎液重量的0.35倍,一边煎煮一边搅拌13分钟,放凉即得药膏。
实施例 5一种治疗足踝扭伤的消肿止痛药膏,取下述重量配比的主要原料制备而成(每份取10g):桑寄生15份,皂角刺6份,红花6份,独行千里8份,木通5份,川芎6份,三七7份,淫羊藿15份,半枝莲4.5份,土茯苓4份,刺五加15份,龟甲9份,三百银11份,无名异(醋炙)10份,山香圆12份,番红花5份,川牛膝5份,穿山龙12份,黑红菇20份,沙棘3份。
一种治疗足踝扭伤的消肿止痛药膏的制备方法,步骤如下:
①取番红花和川牛膝置于小火上,烧至外部焦黑,使药物表面部分炭化,然后研磨备用;
②将皂角刺置于预热好的容器内,用中火炒至表面深黄色,内部浅黄色时取出晾凉至室温,碾碎,用95目筛筛净,制成炒皂角刺;
③将桑寄生、红花、独行千里、木通、川芎、三七、淫羊藿、半枝莲、土茯苓、刺五加、龟甲、三百银、无名异(醋炙)、山香圆、穿山龙、黑红菇和沙棘用黄酒喷匀,黄酒的用量是原料药用量的0.6倍,置于锅内微炒10分钟,晾至酥脆,研磨成细末过100目筛待用;
④将步骤①-③所得物混匀,加水煎煮2次,每次用水量是混合药物的3倍,每次都是先武火煎开,转文火煎煮60分钟,合并煎液;
⑤将步骤④所得煎液中加入白凡士林,白凡士林的用量为煎液重量的0.3倍,一边煎煮一边搅拌10分钟,放凉即得药膏。
实验例:为了验证本发明中药组合物(实施例5)的效果,我们抽取了300名患者进行了药物的实验,平均分为三组,每组100人,实验组及对照组,实验组服用实施例5所得消肿止痛药膏,对照组使用其它治疗足踝扭伤的中药与西药药品。
入选标准:经确诊为足踝扭伤患者,有足踝扭伤临床症状一项或多项。
疗效情况判定标准:1、治愈:使用药物后,不适症状完全消失;2、有效:使用药物后,不适症状减轻或部分消失;3、无效:使用药物后,不适症状无变化。
我们对实验数据进行了精确的统计和数理分析。具体实验结果如下表:
本发明消肿止痛药膏与其它治疗足踝扭伤的药物相比治愈率高,总有效率为98%,比对照组西药有效率高33%,比对照组中药有效率高13%,效果明显优于对照组,该发明的消肿止痛药膏造价低廉,普通百姓长期使用,也不会增加身体和金钱上的负担。临床实验中未出现一例副作用情况,安全性远高于治疗足踝扭伤的同类中西药物,且见效快,使足踝扭伤的治愈不再是可求而不可得的,是目前治疗足踝扭伤最为理想安全的消肿止痛药膏。
本申请的组方为名老中医验方,具有产业化实施的前景。
最后应说明的是,实施例只是本发明最优的具体实施方式而已,并不用于限制本发明,尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (10)
1.一种治疗足踝扭伤的消肿止痛药膏,其特征在于:取下述重量配比的主要原料制备而成:桑寄生10-20份,皂角刺3-9份,红花3-10份,独行千里6-12份,木通3-9份,川芎3-10份,三七5-10份,淫羊藿10-30份,半枝莲3-6份,土茯苓2-6份,刺五加10-30份,龟甲6-12份,三百银9-15份,无名异(醋炙)6-12份,山香圆8-16份,番红花3-9份,川牛膝3-10份,穿山龙8-16份,黑红菇10-30份(优选的,黑红菇10.5-29.5份),沙棘1-5份。
2. 根据权利要求1所述的治疗足踝扭伤的消肿止痛药膏,其特征在于:取下述重量配比的主要原料制备而成:桑寄生12-18份,皂角刺4-7份,红花4-8份,独行千里7-10份,木通4-6份,川芎5-8份,三七6-8份,淫羊藿12-20份,半枝莲4-5份,土茯苓3-5份,刺五加12-28份,龟甲8-10份,三百银10-12份,无名异(醋炙)8-12份,山香圆10-15份,番红花4-8份,川牛膝4-9份,穿山龙10-14份,黑红菇15-25份,沙棘2-4份。
3. 根据权利要求1所述的治疗足踝扭伤的消肿止痛药膏,其特征在于:取下述重量配比的主要原料制备而成:桑寄生15份,皂角刺6份,红花6份,独行千里8份,木通5份,川芎6份,三七7份,淫羊藿15份,半枝莲4.5份,土茯苓4份,刺五加15份,龟甲9份,三百银11份,无名异(醋炙)10份,山香圆12份,番红花5份,川牛膝5份,穿山龙12份,黑红菇20份,沙棘3份。
4. 根据权利要求1-3任一项所述的治疗足踝扭伤的消肿止痛药膏的制备方法,其特征在于:步骤如下:
①取番红花和川牛膝置于小火上,烧至外部焦黑,使药物表面部分炭化,然后研磨备用;
②将皂角刺置于预热好的容器内,用中火炒至表面深黄色,内部浅黄色时取出晾凉至室温,碾碎,用90-100目筛筛净,制成炒皂角刺;
③将桑寄生、红花、独行千里、木通、川芎、三七、淫羊藿、半枝莲、土茯苓、刺五加、龟甲、三百银、无名异(醋炙)、山香圆、穿山龙、黑红菇和沙棘用黄酒喷匀,黄酒的用量是原料药用量的0.4-0.8倍,置于锅内微炒5-15分钟,晾至酥脆,研磨成细末过80-120目筛待用;
④将步骤①-③所得物混匀,加水煎煮2次,每次用水量是混合药物的2-4倍,每次都是先武火煎开,转文火煎煮40-80分钟,合并煎液;
⑤将步骤④所得煎液中加入白凡士林,白凡士林的用量为煎液重量的0.2-0.4倍,一边煎煮一边搅拌5-15分钟,放凉即得药膏。
5. 根据权利要求4所述的消肿止痛药膏的制备方法,其特征在于:步骤②用93-98目筛筛净,制成炒皂角刺(优选用95目筛筛净,制成炒皂角刺)。
6. 根据权利要求4所述的消肿止痛药膏的制备方法,其特征在于:步骤③黄酒的用量是原料药用量的0.5-0.7倍(优选黄酒的用量是原料药用量的0.6倍)。
7. 根据权利要求4所述的消肿止痛药膏的制备方法,其特征在于:步骤③置于锅内微炒8-13分钟(优选置于锅内微炒10分钟)。
8. 根据权利要求4所述的消肿止痛药膏的制备方法,其特征在于:步骤④每次用水量是混合药物的2.5-3.5倍(优选每次用水量是混合药物的3倍)。
9. 根据权利要求4所述的消肿止痛药膏的制备方法,其特征在于:步骤④先武火煎开,转文火煎煮50-70分钟(优选的先武火煎开,转文火煎煮60分钟)。
10. 根据权利要求4所述的消肿止痛药膏的制备方法,其特征在于:步骤⑤白凡士林的用量为煎液重量的0.25-0.35倍,一边煎煮一边搅拌8-13分钟(优选的白凡士林的用量为煎液重量的0.3倍,一边煎煮一边搅拌10分钟)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610103509.8A CN105687935A (zh) | 2016-02-25 | 2016-02-25 | 一种治疗足踝扭伤的消肿止痛药膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610103509.8A CN105687935A (zh) | 2016-02-25 | 2016-02-25 | 一种治疗足踝扭伤的消肿止痛药膏及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105687935A true CN105687935A (zh) | 2016-06-22 |
Family
ID=56223344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610103509.8A Pending CN105687935A (zh) | 2016-02-25 | 2016-02-25 | 一种治疗足踝扭伤的消肿止痛药膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105687935A (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104435524A (zh) * | 2014-08-29 | 2015-03-25 | 郭守进 | 一种治疗脊髓型颈椎病的外敷散剂及其制备方法 |
CN104491111A (zh) * | 2014-12-04 | 2015-04-08 | 广东聚智诚科技有限公司 | 一种中药制剂在制备外敷治疗骨质增生药物中的用途 |
CN104547791A (zh) * | 2015-01-27 | 2015-04-29 | 朱广运 | 一种配合针灸治疗腰腿疼痛的中药喷剂及其制备方法 |
CN104740191A (zh) * | 2015-02-28 | 2015-07-01 | 赵士静 | 治疗髌骨损伤的外敷制剂及制备方法 |
CN104840684A (zh) * | 2015-05-27 | 2015-08-19 | 济南方宇文化传媒有限公司 | 用于治疗跌打损伤后引起的红肿的药贴及其制备方法 |
CN104840890A (zh) * | 2015-05-28 | 2015-08-19 | 陈莉 | 一种用于腰背肌筋膜炎的中药制剂及其制备方法 |
CN105055789A (zh) * | 2015-09-25 | 2015-11-18 | 郭守玲 | 一种缓解软组织损伤疼痛的中药熏洗液及其制备方法 |
-
2016
- 2016-02-25 CN CN201610103509.8A patent/CN105687935A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104435524A (zh) * | 2014-08-29 | 2015-03-25 | 郭守进 | 一种治疗脊髓型颈椎病的外敷散剂及其制备方法 |
CN104491111A (zh) * | 2014-12-04 | 2015-04-08 | 广东聚智诚科技有限公司 | 一种中药制剂在制备外敷治疗骨质增生药物中的用途 |
CN104547791A (zh) * | 2015-01-27 | 2015-04-29 | 朱广运 | 一种配合针灸治疗腰腿疼痛的中药喷剂及其制备方法 |
CN104740191A (zh) * | 2015-02-28 | 2015-07-01 | 赵士静 | 治疗髌骨损伤的外敷制剂及制备方法 |
CN104840684A (zh) * | 2015-05-27 | 2015-08-19 | 济南方宇文化传媒有限公司 | 用于治疗跌打损伤后引起的红肿的药贴及其制备方法 |
CN104840890A (zh) * | 2015-05-28 | 2015-08-19 | 陈莉 | 一种用于腰背肌筋膜炎的中药制剂及其制备方法 |
CN105055789A (zh) * | 2015-09-25 | 2015-11-18 | 郭守玲 | 一种缓解软组织损伤疼痛的中药熏洗液及其制备方法 |
Non-Patent Citations (2)
Title |
---|
杨彦均等主编: "《中医药膳手册》", 30 June 2004, 羊城晚报出版社 * |
邓伟等: "活血利水法治疗急性踝关节扭伤", 《中药材》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1302801C (zh) | 治疗子宫肌瘤的中药复方制剂 | |
CN103520654A (zh) | 一种用于治疗膝骨关节炎的中药组合物及其制备方法 | |
CN103735791B (zh) | 一种治疗腰椎、骨质疾病的中药组合物及其制备方法 | |
CN104353019A (zh) | 舒经调脏的中药热敷袋及其制备方法 | |
CN102631655B (zh) | 一种治疗冠心病的药物及其制备方法 | |
CN105031013A (zh) | 一种治疗腰椎骨质增生的药物及其制备方法 | |
CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
CN103933285A (zh) | 一种能加快手术后骨折愈合的内服中药组方 | |
CN102836309B (zh) | 治疗骨折的续筋接骨丸 | |
CN105125910A (zh) | 治疗坐骨神经痛的中药组合物及其制备方法 | |
CN102743550B (zh) | 加速骨折手术后愈合速度的药物组合物、制备方法及应用 | |
CN105106854A (zh) | 一种治疗腰椎病的中药制剂 | |
CN104771637A (zh) | 治疗胆结石的利胆排石剂及制备方法 | |
CN104758701A (zh) | 一种胃结石碎石后护理治疗的药物及其制备方法 | |
CN104398927A (zh) | 治疗膝关节滑膜炎的中药制剂 | |
CN105687935A (zh) | 一种治疗足踝扭伤的消肿止痛药膏及其制备方法 | |
CN104027451B (zh) | 一种治疗肝肾不足证型坐骨神经痛的中药 | |
CN105687934A (zh) | 一种治疗肩周炎的组合物药方及其制备方法 | |
CN102836276A (zh) | 治疗骨性关节炎的骨刺软化丸 | |
CN106267075A (zh) | 一种用于治疗强直性脊柱炎的中药胶囊 | |
CN105031335A (zh) | 一种胃结石微波碎石后护理治疗的药物及其制备方法 | |
CN104873858A (zh) | 一种治疗功能性痛经的中药组合物 | |
CN105267886A (zh) | 一种治疗骨肉瘤的中药组合物及其膏药制备方法 | |
CN105435025A (zh) | 一种有效治疗骨质疏松的纯中药胶囊 | |
CN104771529A (zh) | 一种治疗肝肾亏虚型创伤性关节炎的药物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160622 |
|
RJ01 | Rejection of invention patent application after publication |